| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.093 | 0.08 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.097 | 0.08 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.088 | 0.08 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.08 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |